1,258.00p+39.00 (+3.20%)06 Jul 2022, 18:01
Jump to:
Abcam PLC Fundamentals
Company Name | Abcam PLC | Last Updated | 2022-07-06 |
---|---|---|---|
Industry | Biotechnology | Sector | Healthcare |
Shares in Issue | 228.968 m | Market Cap | £2.88 bn |
PE Ratio | 185.19 | Dividend per Share | 0 |
Dividend Yield | 0 | Dividend Cover | 0 |
EPS | £0.08 | EPS Growth (%) | -0.26 |
PEG | 0 | DPS Growth (%) | 0 |
Debt Ratio | 0.1340 | Debt Equity Ratio | 0.1613 |
Asset Equity Ratio | 1.2990 | Cash Equity Ratio | 0.3465 |
Quick Ratio | 3.9806 | Current Ratio | 4.78 |
Price To Book Value | 4.2535 | ROCE | 0 |
Abcam PLC Dividends
Type | Ex-Date | Pay Date | Currency | Net Dividend | Year Total |
---|---|---|---|---|---|
Interim | 2020-03-19 | 2020-04-17 | GBP | 0.0355 | |
Prelim | 2019-11-07 | 2019-11-29 | GBP | 0.0858 |
Abcam PLC Company Financials
Assets | 2021 | 2020 | 2019 |
---|---|---|---|
Tangible Assets | £161.70 m | £164.70 m | £37.10 m |
Intangible Assets | £599.00 m | £345.10 m | £225.50 m |
Investments | £3.50 m | £7.00 m | £800,000.00 |
Total Fixed Assets | £774.60 m | £530.50 m | £272.80 m |
Stocks | £58.20 m | £40.70 m | £36.00 m |
Debtors | £42.10 m | £39.70 m | £43.10 m |
Cash & Equivalents | £95.10 m | £187.30 m | £87.10 m |
Other Assets | £10.40 m | £13.70 m | £9.40 m |
Total Assets | £986.10 m | £809.30 m | £444.60 m |
Liabilities | 2021 | 2020 | 2019 |
---|---|---|---|
Creditors within 1 year | £187.20 m | £159.60 m | £45.30 m |
Creditors after 1 year | £142.80 m | £148.80 m | £16.20 m |
Other Liabilities | 0 | 0 | 0 |
Total Liabilities | £330.00 m | £308.40 m | £61.50 m |
Net assets | £656.10 m | £500.90 m | £383.10 m |
Equity | 2021 | 2020 | 2019 |
---|---|---|---|
Called up share capital | £500,000.00 | £400,000.00 | £400,000.00 |
Share Premium | £268.30 m | £138.20 m | £27.00 m |
Profit / Loss | £20.30 m | £8.30 m | £55.60 m |
Other Equity | £656.10 m | £500.90 m | £383.10 m |
Preference & Minorities | 0 | 0 | 0 |
Total Capital Employed | £656.10 m | £500.90 m | £383.10 m |
Ratios | 2021 | 2020 | 2019 |
---|---|---|---|
Debt Ratio | £0.19 | 0 | 0 |
Debt-to-Equity | £0.24 | 0 | 0 |
Assets / Equity | 1.2990 | 1.2990 | 1.2990 |
Cash / Equity | 0.3465 | 0.3465 | 0.3465 |
EPS | £0.17 | £0.16 | £0.22 |
Cash Flow | 2021 | 2020 | 2019 |
---|---|---|---|
Cash from operating activities | £96.20 m | £63.00 m | £69.30 m |
Cashflow before financing | £222.60 m | £247.60 m | £44.60 m |
Increase in Cash | -£91.10 m | £99.50 m | -£4.40 m |
Income | 2021 | 2020 | 2019 |
---|---|---|---|
Turnover | £462.90 m | £260.00 m | £259.90 m |
Cost of sales | £133.70 m | £79.80 m | £76.70 m |
Gross Profit | £329.20 m | £180.20 m | £183.20 m |
Operating Profit | £24.40 m | £10.40 m | £55.30 m |
Pre-Tax profit | £20.30 m | £8.30 m | £55.60 m |
Abcam PLC Company Background
Sector | Healthcare |
---|---|
Activities | Abcam PLC is a biotechnology company that develops and provides antibodies to life science research and clinical communities. The company's products allow research into the role of signaling and regulatory molecules and proteins in biological pathways. Such research ultimately leads to treatments for diseases such as cancer and immune deficiency disorders. Abcam's focused on broadening its product range, improving speed to market, and accessing underpenetrated consumer groups in its markets. The company also selectively pursues partnerships and acquisitions. |
Latest Interim Date | 13 Sep 2021 |
Latest Fiscal Year End Date | 14 Mar 2022 |
Abcam PLC Directors
Appointed | Name | Position |
---|---|---|
2009-11-03 | Mr. Timothy George Dye | Non-Executive Director |
2021-08-13 | Dr. Jonathan Simon Milner | Non-Executive Director,Deputy Chairman |
2016-09-26 | Mr. Jeffrey Michel Iliffe | Executive Director,Chief Financial Officer |
2011-08-09 | Mr. Mark John Alexander Webster | Non-Executive Director |
2020-09-18 | Lady Louise Alexandra Virginia Charlotte Patten of Wincanton | Independent Director |
2014-11-03 | Mr. Michael Redmond | Non-Executive Director,Chairman |
2020-09-18 | Mr. Giles Francis Bertram Kerr | Independent Director |
2014-11-03 | Mr. Peter Stephen Keen | Non-Executive Director |
2012-10-22 | Professor Tony Kouzarides | Non-Executive Director |
2017-09-22 | Dr. David James Warwick | Executive Director,Chief Operating Officer |
2020-09-18 | Mr. Peter Vance Allen | Chairman of the Board |
2016-10-31 | Dr. Anthony Francis Martin | Non-Executive Director |
2018-09-24 | Mr. Murray Edwin Hennessy | Executive Director,Chief Executive Officer |
2009-09-16 | Dr. David Douglas Cleevely PhD,FIET,FREng | Non-Executive Director,Chairman |
2011-08-09 | Dr. Edward William Eddie Powell PhD,FCA | Executive Director,Finance Director |
2016-10-31 | Mr. Michael Alexander Nunes Ross | Non-Executive Director |
2019-11-13 | Ms. Susan Elizabeth Harris | Non-Executive Director |
2020-02-03 | Mr. Gavin Hilary James Wood | Executive Director,Chief Financial Officer |
2021-11-12 | Mr. Alan Thomas Hirzel | Chief Executive Officer and Director |
2020-09-18 | Ms. Mara Glickman Aspinall | Independent Director |
2019-10-03 | Ms. Suzanne Smith | Legal Officer and Company Secretary |
2022-03-17 | Mr. Michael Shaun Baldock | Chief Financial Officer and Director |
Abcam PLC Contact Details
Company Name | Abcam PLC |
---|---|
Address | Milton Road, 330 Cambridge Science Park, Cambridge, CB4 0FL |
Telephone | +44 01223 696000 |
Website | https://www.abcam.com |
Abcam PLC Advisors
Registrar | Equiniti Ltd. |
---|---|
Phone | +44 1214157082 |
Financial PR Adviser | FTI Consulting Inc |
---|---|
Phone | +44 2037271000 |
Fax | +44 2037271007 |
Nominated Adviser | J.P. Morgan Cazenove |
---|---|
Phone | +44 2077424000 |
Stockbroker | J.P. Morgan Cazenove Ltd |
---|---|
Phone | +44 2077424000 |
Remuneration Consultant | Deloitte & Touche LLP |
---|---|
Phone | +44 2079363000 |
Fax | +44 2075831198 |
Auditor | PricewaterhouseCoopers LLP |
---|---|
Phone | +44 1223460055 |
Fax | +44 1223552336 |
Bank | National Westminster Bank PLC |
---|
Solicitor | Eversheds Sutherland |
---|---|
Phone | +44 2079194500 |
Fax | +44 2079194919 |
Sign up to our
daily email
Subscribe to the latest investing news by entering your email address below
You can opt out at any time.
For five days a week you will get
- The latest company news
- Insight into investment trends
- Round-up of director's buys and sells
- Articles from Shares magazine

Plus more useful investment content and occasional promotional offers.
Market Overview
UK 350 Risers and Fallers
Risers
Company | Price | % Chg |
---|---|---|
Trainline PLC | 340.00 | 20.61 |
Scottish Mortgage Investment Trust PLC | 776.00 | 6.86 |
Chrysalis Investments Limited | 95.70 | 6.33 |
4Imprint Group PLC | 2,440.00 | 6.32 |
Baltic Classifieds Group PLC | 138.00 | 5.83 |
Liontrust Asset Management PLC | 912.00 | 5.68 |
Fallers
Company | Price | % Chg |
---|---|---|
Tullow Oil PLC | 39.66 | -6.20 |
Fresnillo PLC | 685.60 | -5.67 |
Harbour Energy PLC | 298.50 | -5.60 |
Energean PLC | 932.00 | -5.28 |
Hochschild Mining PLC | 79.90 | -3.73 |
Diversified Energy Company PLC | 107.30 | -2.98 |